Literature DB >> 16362831

Pallido-pyramidal syndrome with blepharospasm and good response to levodopa.

Trilochan Srivastava, Vinay Goyal, Sumit Singh, Garima Shukla, Madhuri Behari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16362831     DOI： 10.1007/s00415-005-0852-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  Case report of pallido-pyramidal disease with supplementary motor area involvement.

Authors:  P F Pradat; C Dupel-Pottier; L Lacomblez; F Salachas; V Meininger; L Lacomblez; L Spelle; I Bonnaud; M J Ribeiro; P Remy; Y Samson
Journal:  Mov Disord       Date:  2001-07       Impact factor: 10.338

2.  Sporadic variety of pallido-pyramidal syndrome.

Authors:  J Kalita; U K Misra; B K Das
Journal:  Neurol India       Date:  2003-09       Impact factor: 2.117

3.  Pallido-pyramidal disease.

Authors:  C DAVISON
Journal:  J Neuropathol Exp Neurol       Date:  1954-01       Impact factor: 3.685

Review 4.  [Pallido-pyramidal syndrome: an unrecognized entity].

Authors:  C Tranchant; C Boulay; J M Warter
Journal:  Rev Neurol (Paris)       Date:  1991       Impact factor: 2.607

5.  Pallido-pyramidal syndrome treated with levodopa.

Authors:  G Horowitz; J Greenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-03       Impact factor: 10.154

6.  Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36.

Authors:  D J Hampshire; E Roberts; Y Crow; J Bond; A Mubaidin; A L Wriekat; A Al-Din; C G Woods
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

7.  Positron emission tomography scanning in essential blepharospasm.

Authors:  John B Kerrison; Jack L Lancaster; Frank E Zamarripa; Londe A Richardson; John C Morrison; David E E Holck; Kurt W Andreason; Sean M Blaydon; Peter T Fox
Journal:  Am J Ophthalmol       Date:  2003-11       Impact factor: 5.258

8.  Striatal dopaminergic denervation in pallidopyramidal disease demonstrated by positron emission tomography.

Authors:  P Remy; H Hosseini; J D Degos; Y Samson; Y Agid; J M Warter; M Vidailhet
Journal:  Ann Neurol       Date:  1995-12       Impact factor: 10.422

9.  Familial levodopa-responsive parkinsonian-pyramidal syndrome.

Authors:  P Nisipeanu; A Kuritzky; A D Korczyn
Journal:  Mov Disord       Date:  1994-11       Impact factor: 10.338

10.  Positron emission tomography in patients with benign essential blepharospasm.

Authors:  B Esmaeli-Gutstein; C Nahmias; M Thompson; M Kazdan; J Harvey
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1999-01       Impact factor: 1.746
  10 in total
  1 in total

1.  Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays.

Authors:  Seyedmehdi Shojaee; Farzad Sina; Setareh Sadat Banihosseini; Mohammad Hossein Kazemi; Reza Kalhor; Gholam-Ali Shahidi; Hossein Fakhrai-Rad; Mostafa Ronaghi; Elahe Elahi
Journal:  Am J Hum Genet       Date:  2008-06       Impact factor: 11.025
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.